VECTORMUNE® AI

COMPOSITION

VECTORMUNE® AI contains a genetically engineered Marek's Disease vaccine of serotype 3 (turkey Herpes virus or HVT) expressing Avian Influenza key protective antigens. This Marek's Disease vaccine containing serotype 3 is presented in a frozen cell associated form.

INDICATIONS

VECTORMUNE ® AI is recommended for use in healthy one day-old-chicks as an aid in the prevention of Avian Influenza caused by the H5 subtype and Marek's Disease.

ADMINISTRATION AND DOSAGE

Prior to use, the vaccine must be diluted appropriately with the vaccine diluents as stated in the package insert. Immediately use the vaccine and mix occasionally to ensure uniform suspension of cells. The vaccine is administered subcutaneously with a 0.2 ml diluted vaccine dose to one-day-old chicks in the back of the neck.

STORAGE

Store this vaccine in liquid nitrogen.

PACKAGED

2000 dose ampoules.

VECTORMUNE® ND

COMPOSITION

VECTORMUNE® ND contains a genetically engineered Marek Disease virus of serotype 3 (turkey Herpes virus or HVT) expressing a key protective antigen of Newcastle Disease virus. This Marek Disease vaccine containing serotype 3 is presented in a frozen cell-associated form.

INDICATIONS

VECTORMUNE® ND is recommended for use in healthy one-day-old chicks or in 18 to 19-day-old embryonated chicken eggs as an aid in the prevention of Newcastle Disease and Marek Disease.

ADMINISTRATION AND DOSAGE

Prior to use, the vaccine must be thawed and diluted appropriately with the vaccine diluents as started in the package insert. Immediately use the vaccine and mix occasionally to ensure uniform suspension of cells.
For in ovo administration, embryos are inoculated with one full dose of vaccine (in 0,05 or 0,1 ml diluent / dose).
For day-old vaccination, one-day-old chicks are subcutaneously vaccinated with one full dose of vaccine ( in 0,2 ml of diluent / dose) in the back of the neck.

STORAGE

Store this vaccine in liquid nitrogen.

PACKAGED

2,000 doses ampoule.

VECTORMUNE®FP MG

COMPOSITION

VECTORMUNE®FP MG is a genetically engineered, live Fowl Pox virus vaccine for use in chickens . The Fowl Pox virus has been genetically modified to express key protective Mycoplasma gallisepticum (MG) antigens . This vaccine is presented in a freeze-dried preparation.

INDICATIONS

VECTORMUNE® FP MG is recommended for wing web application to healthy, susceptible chickens 3 to 5 weeks of age , but at least four weeks prior to the onset of egg production.

VECTORMUNE® FP MG Is indicated as an aid in the prevention of Fowl Pox and Mycoplasma  gallisepticum infections. Chickens receiving this vaccine must not have been previously exposed to Fowl Pox virus or vaccine due to interference with immunity following vaccination.

ADMINISTRATION AND DOSAGE

Wing Web: Insert the applicator into the webbed portion of the wing avoiding feathers, muscle, bone and blood vessels (0.01 ml dose/bird). Vaccine should be used within one hour.

STORAGE

Store vaccine between +2°C and +8°C or 35°F and 45°F.Protect from light.

PACKAGED

10 X 1,000 dose vials and wing web applicators.